Department of Pediatrics, Peking University First Hospital, Beijing, China.
Key Laboratory of Molecular Cardiology, Ministry of Education, Beijing, China.
Br J Pharmacol. 2018 Apr;175(8):1114-1125. doi: 10.1111/bph.13829. Epub 2017 May 30.
Sulfur-containing gaseous signal molecules including hydrogen sulphide and sulfur dioxide were previously recognized as toxic gases. However, extensive studies have revealed that they can be generated in the cardiovascular system via a sulfur-containing amino acid metabolic pathway, and have an important role in cardiovascular physiology and pathophysiology. Ion channels are pore-forming membrane proteins present in the membrane of all biological cells; their functions include the establishment of a resting membrane potential and the control of action potentials and other electrical signals by conducting ions across the cell membrane. Evidence has now accumulated suggesting that the sulfur-containing gaseous signal molecules are important regulators of ion channels and transporters. The aims of this review are (1) to discuss the recent experimental evidences in the cardiovascular system regarding the regulatory effects of sulfur-containing gaseous signal molecules on a variety of ion channels, including ATP-sensitive potassium, calcium-activated potassium, voltage-gated potassium, L- and T-type calcium, transient receptor potential and chloride and sodium channels, and (2) to understand how the gaseous signal molecules affect ion channels and cardiovascular diseases.
This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.
含硫气体信号分子,包括硫化氢和二氧化硫,曾被认为是有毒气体。然而,大量研究表明,它们可以通过含硫氨基酸代谢途径在心血管系统中产生,并且在心血管生理学和病理生理学中具有重要作用。离子通道是存在于所有生物细胞膜中的孔形成膜蛋白;它们的功能包括建立静息膜电位和通过跨细胞膜传导离子来控制动作电位和其他电信号。现在已经有大量证据表明,含硫气体信号分子是离子通道和转运蛋白的重要调节剂。本综述的目的是:(1)讨论心血管系统中关于含硫气体信号分子对多种离子通道(包括 ATP 敏感性钾、钙激活钾、电压门控钾、L 型和 T 型钙、瞬时受体电位和氯、钠通道)的调节作用的最新实验证据;(2)了解气体信号分子如何影响离子通道和心血管疾病。
本文是心血管疾病中小分子专题的一部分。要查看该部分中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.